In this phase, the role of Cxs is typically opposite, as the upregulation of Cx expression is most often positively associated with metastatic cancer, such as the role of Cx43/Cx26/Cx30 in metastatic breast cancer and prostate cancer bone metastasis [32,33,34,35,36]. Here, GJA1 is linked to prostate carcinoma.